The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

6626–6650 of 18015

  • CriticalFDA (Drugs)·D-0655-2020·2020-01-22

    FDA Recalls Unapproved Stallion Platinum 30000 Capsules Containing Tadalafil

    Motto International Corp is recalling Stallion Platinum 30000 Capsules because FDA analysis found the unapproved product contains tadalafil.

    Product
    Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-0654-2020·2020-01-22

    FDA Recalls Unapproved Bull Platinum 30000 Capsules Containing Tadalafil

    Motto International Corp is recalling Bull Platinum 30000 Capsules because FDA analysis found the product contains tadalafil, a prescription drug, and it was marketed without an approved NDA or ANDA.

    Product
    Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-0864-2020·2020-01-22

    Hikma Recalls Ketorolac Tromethamine Injection Due to Particulate Matter

    Hikma Pharmaceuticals is recalling specific lots of Ketorolac Tromethamine Injection because of the presence of polydimethylsiloxane particles.

    Product
    KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0656-2020·2020-01-22

    FDA Recalls Rhino 7 Platinum 30000 Capsules for Unapproved Tadafila Content

    Motto International Corp is recalling Rhino 7 Platinum 30000 Capsules because FDA analysis found the product contains tadalafil, an unapproved active ingredient.

    Product
    Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0732-2020·2020-01-22

    Assurance Infusion Recalls Fentanyl Injection Due to Sterility Concerns

    Assurance Infusion is recalling Fentanyl 5mg/mL injection syringes due to a lack of sterility assurance. The product was distributed nationwide in the United States.

    Product
    FENTANYL 5MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0673-2020·2020-01-22

    Assurance Infusion Recalls Multi-Drug Syringes Due to Sterility Concerns

    Assurance Infusion is recalling specific lots of a multi-drug injection syringe due to a lack of sterility assurance.

    Product
    BAC 400MCG/BUP 20MG/HYDROM 15MG/SUF 1000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0757-2020·2020-01-22

    Assurance Infusion Recalls Morphine Syringes Due to Sterility Concerns

    Assurance Infusion is recalling specific lots of Morphine 30mg/mL injection syringes due to a lack of sterility assurance. The affected products were distributed nationwide.

    Product
    MORPHINE 30MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0706-2020·2020-01-22

    Assurance Infusion Recalls BUP 3 mg/MORP 15 mg/mL Injection Syringes

    Assurance Infusion is recalling BUP 3 mg/MORP 15 mg/mL Injection syringes due to a lack of sterility assurance. The recall covers specific lots distributed nationwide.

    Product
    BUP 3 mg/MORP 15 mg/mL Inj. in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0683-2020·2020-01-22

    FDA Recalls Assurance Infusion Syringes Due to Sterility Assurance Issues

    Assurance Infusion is recalling 20 mL syringes of BUP 15MG/CLON 300MCG/FENT 1500MCG/ML injection due to a lack of sterility assurance.

    Product
    BUP 15MG/CLON 300MCG/ FENT 1500MCG/ML(40) INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0688-2020·2020-01-22

    Assurance Infusion Recalls BUP 1MG//ML/HYDROM 7MG Injection Due to Sterility Concerns

    Assurance Infusion is recalling BUP 1MG//ML/HYDROM 7MG Injection in 20 mL syringes due to a lack of sterility assurance. The recall covers nationwide distribution in the United States.

    Product
    BUP 1MG//ML/HYDROM 7MG INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0689-2020·2020-01-22

    Assurance Infusion Recalls Multi-Drug Injection Syringes Due to Sterility Concerns

    Assurance Infusion is recalling specific syringes of a multi-drug injection due to a lack of sterility assurance. The affected products were distributed nationwide.

    Product
    BUP 2.5MG/ CLONI 5MCG/ FENT 200MCG/ SUF 50MCG/ML (40) INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0676-2020·2020-01-22

    Assurance Infusion Recalls Baclofen Syringes Due to Sterility Assurance Concerns

    Assurance Infusion is recalling specific lots of Baclofen injection syringes due to a lack of sterility assurance. The product was distributed nationwide.

    Product
    BACLOFEN 2000MCG/ML (40) INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0752-2020·2020-01-22

    Assurance Infusion Recalls Morphine Injection Due to Sterility Concerns

    Assurance Infusion is recalling Morphine 15mg/mL injection syringes due to a lack of sterility assurance. The recall covers products distributed nationwide in the United States.

    Product
    MORPHINE 15MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0697-2020·2020-01-22

    Assurance Infusion Recalls BUP 2MG/HYDROM 2MG/ML Injection Syringes

    Assurance Infusion is recalling BUP 2MG/HYDROM 2MG/ML Injection syringes due to a lack of sterility assurance. The recall covers nationwide distribution.

    Product
    BUP 2MG/ HYDROM 2MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0691-2020·2020-01-22

    Assurance Infusion Recalls BUP/CLON/FENT Injection Due to Sterility Concerns

    Assurance Infusion is recalling specific lots of BUP 20MG/CLON 250MCG/FENT 7200MCG/ML Injection due to a lack of sterility assurance.

    Product
    BUP 20MG/CLON 250MCG/FENT 7200MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0660-2020·2020-01-22

    Sun Pharma Recalls Sumatriptan Tablets Due to Impurity Failures

    Sun Pharmaceutical Industries is recalling 207,585 blisters of Sumatriptan Succinate 100 mg tablets due to failed impurity specifications.

    Product
    Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0719-2020·2020-01-22

    Assurance Infusion Recalls BUP 9MG/ HYDROM 25MG/ SUF 110MCG/ML INJ Syringes

    Assurance Infusion is recalling BUP 9MG/ HYDROM 25MG/ SUF 110MCG/ML INJ syringes due to a lack of sterility assurance.

    Product
    BUP 9MG/ HYDROM 25MG/ SUF 110MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0704-2020·2020-01-22

    Assurance Infusion Recalls BUP 35MG/MORP 10MG/ML Injection Syringes

    Assurance Infusion is recalling BUP 35MG/MORP 10MG/ML Injection syringes due to a lack of sterility assurance. The product was distributed nationwide.

    Product
    BUP 35MG/MORP 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0733-2020·2020-01-22

    Assurance Infusion Recalls Fentanyl Injection Due to Sterility Concerns

    Assurance Infusion is recalling Fentanyl 800mcg/mL injection syringes due to a lack of sterility assurance. The product was distributed nationwide in the United States.

    Product
    FENTANYL 800MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0772-2020·2020-01-22

    Assurance Infusion Recalls Testosterone Cypionate Injections Due to Sterility Concerns

    Assurance Infusion is recalling 166 vials of Testosterone Cypionate 200mg/mL oil injection due to a lack of sterility assurance. The product was distributed nationwide.

    Product
    TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Infusion (713) 533-8800
    Category
    Drug
    Distribution
    Distributed nationwide